Bonsity Injection, Solution
Product Images NDC 47781-852

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Bonsity (NDC 47781-852). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alvogen Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Bonsity Carton)

Bonsity teriparatide injection 250 mcg/mL in a 560 mcg/2.24 mL prefilled pen carton, labeled for subcutaneous use. The label notes 20 mcg per dose given once daily, for single-patient use only, and includes storage instructions to refrigerate and not freeze. Distributed by Alvogen Inc., the label also includes dosing and handling warnings along with device usage instructions and contact information.*

FDA Label Image

Logo (Bonsity Logo)

FDA Label Image

Figure-1 (Figure1)

A line graph comparing the percent of patients with nonvertebral osteoporotic fractures over 20 months since randomization between two groups: one receiving teriparatide and the other receiving placebo. The teriparatide group shows a consistently lower percentage of fractures compared to the placebo group throughout the period.*

FDA Label Image

Ifu-fig-a (Ifu Fig A)

An instructional diagram of the Bonsity injection device showing labeled parts including the outer needle cover, inner needle cover, needle, paper tab, white cap, medicine cartridge, plunger, label, teal body, instruction window, and black injection button. The diagram specifies recommended needle gauges from 29 to 31 and visually details each component of the subcutaneous injection pen.*

FDA Label Image

Ifu-fig-b (Ifu Fig B)

An instructional illustration labeled Figure B shows hands preparing a prefilled syringe for injection. One hand holds a syringe upright while the other hand removes a protective cap from the syringe needle by pulling it straight off.*

FDA Label Image

Ifu-fig-c (Ifu Fig C)

An instructional illustration labeled 'Figure C' showing a person holding the Bonsity teriparatide injection pen near their eye with an arrow indicating the pen should not be placed or injected in the eye area. The image demonstrates safe handling or usage instructions for the subcutaneous injection device.*

FDA Label Image

Ifu-fig-d (Ifu Fig D)

An instructional illustration labeled as Figure D showing a hand holding a syringe-like device with a purple cap being removed by lifting it upwards, indicating the step to detach the cap from a subcutaneous injection device.*

FDA Label Image

Ifu-fig-e-f (Ifu Fig E F)

Illustration showing how to remove a cap from a prefilled syringe containing solution for injection. The top image (Figure E) depicts pulling off the cap horizontally, while the bottom image (Figure F) shows twisting the cap upward to detach it from the syringe.*

FDA Label Image

Ifu-fig-g (Ifu Fig G)

An instructional illustration depicting how to remove the protective cap from the needle of a Bonsity 250 ug/mL teriparatide injection pen prior to subcutaneous administration. The image shows hands grasping the injection device and cap, with an arrow indicating the direction to pull the cap off.*

FDA Label Image

Ifu-fig-h (Ifu Fig H)

Instructional illustration showing hands holding an injection pen device labeled Bonsity, with an arrow indicating pulling the black cap off the pen. This image likely demonstrates how to prepare the teriparatide injection for use.*

FDA Label Image

Ifu-fig-i (Ifu Fig I)

An instructional diagram labeled "Figure I" showing parts of a device with a teal section containing an instruction window marked with a red triangle, a yellow shaft with a red vertical stripe, and a black end portion. The diagram highlights the red stripe, instruction window, and yellow shaft components.*

FDA Label Image

Ifu-fig-j (Ifu Fig J)

An instructional diagram showing hands removing a protective cap from the needle of an injection pen device. A close-up inset highlights the cap being pulled straight off the needle, indicating preparation for subcutaneous injection of Bonsity (teriparatide) 250 mcg/mL injection solution.*

FDA Label Image

Ifu-fig-k (Ifu Fig K)

An instructional illustration labeled 'Figure K' showing a hand holding a Bonsity injection pen (teriparatide 250 mcg/mL) subcutaneously. The pen is depicted with a yellow label and a downward arrow indicating insertion of the needle into the skin.*

FDA Label Image

Ifu-fig-l (Ifu Fig L)

An instructional illustration labeled Figure L showing a hand pressing down the top of a pen-style injection device with an arrow indicating the pressing motion. The other hand holds a finger near the injection prong, suggesting preparation for subcutaneous injection with the device.*

FDA Label Image

Ifu-fig-m (Ifu Fig M)

Instructional illustration showing a hand holding a Bonsity injection pen, indicating to hold the device while counting to five seconds during subcutaneous injection administration. The image visually guides on the proper technique and timing for use.*

FDA Label Image

Ifu-fig-n (Ifu Fig N)

An instructional illustration showing a hand holding a Bonsity teriparatide injection pen. The image depicts lifting the pen from the cap with a black arrow indicating upward movement. The word 'LIFT' appears at the top, and 'Figure N' is labeled at the bottom, demonstrating a step in preparing the injection pen for subcutaneous administration.*

FDA Label Image

Ifu-fig-o (Ifu Fig O)

An illustration labeled Figure O showing a close-up of a device button with a yellow square containing a red play symbol. A green checkmark is displayed above the button, indicating a correct or positive action related to the device operation.*

FDA Label Image

Ifu-fig-p-q (Ifu Fig P Q)

An instructional diagram showing how to assemble or use a prefilled injection device, with two panels labeled 'Scoop Up' and 'Figure P' and 'Figure Q,' demonstrating removing or attaching a protective cap from the syringe tip by pulling or scooping it off with fingers.*

FDA Label Image

Ifu-fig-r (Ifu Fig R)

An instructional diagram showing hands preparing a prefilled syringe for injection. The image depicts the removal of a cap or cover from the syringe by twisting or pulling downward, indicated by an arrow. It is labeled as Figure R.*

FDA Label Image

Ifu-fig-s (Ifu Fig S)

An instructional illustration depicting how to prepare or use a prefilled syringe, showing a hand removing a cap or protective cover from the syringe tip, with an arrow indicating the direction to pull.*

FDA Label Image

Ifu-fig-t (Ifu Fig T)

An instructional illustration labeled as Figure T showing a hand disposing of a syringe or needle into a red sharps container labeled "SHARPS CONTAINER." This depicts safe disposal of injectable materials typically associated with subcutaneous injections.*

FDA Label Image

Ifu-fig-u (Ifu Fig U)

An instructional illustration labeled 'Figure U' showing two hands assembling or preparing a pen-type injector device, with an arrow indicating the direction to pull or insert a component. This likely relates to the preparation or use of an injectable medication device.*

FDA Label Image

Ifu-fig-v (Ifu Fig V)

An instructional illustration showing a medication pen device being inserted into a refrigerator. The diagram highlights the proper storage method for the device by placing it inside a refrigerator door compartment labeled as 'Figure V'.*

FDA Label Image

Ifu-important-info (Ifu Important Info)

FDA Label Image

Ifu-ts-problem-a (Ifu Ts Problem A)

Illustration showing a teal device with a yellow and red rectangular button, covered by a black cap on the right side. The device is overlaid with a red prohibition circle and diagonal line, indicating a 'do not' instruction related to the device or button.*

FDA Label Image

Chemical Structure (Structure)

A chemical structure diagram representing the amino acid sequence of teriparatide. The linear peptide chain is numbered from 1 to 34, illustrating the sequence of individual amino acids in the active ingredient of Bonsity 250 mcg/mL injection.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.